SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-13-157712
Filing Date
2013-04-17
Accepted
2013-04-17 06:25:33
Documents
9
Period of Report
2013-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d523131d6k.htm 6-K 30938
2 GRAPHIC g523131g25d46.jpg GRAPHIC 233870
3 GRAPHIC g523131g30a67.jpg GRAPHIC 9000
4 GRAPHIC g523131g31u03.jpg GRAPHIC 318151
5 GRAPHIC g523131g50b16.jpg GRAPHIC 359985
6 GRAPHIC g523131g60e10.jpg GRAPHIC 345586
7 GRAPHIC g523131g66n33.jpg GRAPHIC 134794
8 GRAPHIC g523131img010.jpg GRAPHIC 211057
9 GRAPHIC g523131img011.jpg GRAPHIC 302948
  Complete submission text file 0001193125-13-157712.txt   2672101
Mailing Address LEVEL 1 1 - 7 WATERLOO ROAD NORTH RYDE NSW C3 2113
Business Address LEVEL 1 1 - 7 WATERLOO ROAD NORTH RYDE NSW C3 2113 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 13765723
SIC: 2834 Pharmaceutical Preparations